|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0008976,
umls-concept:C0015133,
umls-concept:C0020823,
umls-concept:C0030705,
umls-concept:C0205420,
umls-concept:C0439801,
umls-concept:C0442027,
umls-concept:C0684249,
umls-concept:C0817096,
umls-concept:C0851346,
umls-concept:C1274040,
umls-concept:C1514695
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2000-9-14
|
|
pubmed:abstractText |
The combination of cisplatin, ifosfamide, and oral etoposide (PIEo) given concurrently with accelerated hyperfractionated thoracic radiation was studied in patients with limited small-cell lung cancer in a phase II trial to assess response, survival, and toxicity.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2990-5
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10944132-Administration, Oral,
pubmed-meshheading:10944132-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10944132-Carcinoma, Small Cell,
pubmed-meshheading:10944132-Chemotherapy, Adjuvant,
pubmed-meshheading:10944132-Cisplatin,
pubmed-meshheading:10944132-Combined Modality Therapy,
pubmed-meshheading:10944132-Cranial Irradiation,
pubmed-meshheading:10944132-Disease-Free Survival,
pubmed-meshheading:10944132-Dose Fractionation,
pubmed-meshheading:10944132-Esophagitis,
pubmed-meshheading:10944132-Etoposide,
pubmed-meshheading:10944132-Female,
pubmed-meshheading:10944132-Humans,
pubmed-meshheading:10944132-Ifosfamide,
pubmed-meshheading:10944132-Lung Neoplasms,
pubmed-meshheading:10944132-Male,
pubmed-meshheading:10944132-Middle Aged,
pubmed-meshheading:10944132-Neutropenia,
pubmed-meshheading:10944132-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.
|
|
pubmed:affiliation |
University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. bglisson@mdanderson.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study,
Clinical Trial, Phase I
|
